Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
Hoxworth, FC Cincinnati celebrate life-saving donors with exclusive May giveaway
April 27, 2026
Hoxworth Blood Center, University of Cincinnati, is asking donors to score big for their community this May with an exclusive 40 oz. FC Cincinnati–themed tumbler available to donors at the seven neighborhood donor centers and select mobile drives while supplies last.
Some high school students do take gap years
April 27, 2026
Cleveland Magazine spoke with Teneisha Dyer, assistant dean for student recruitment and marketing at the UC College of Education, Criminal Justice, Human Services and Information Technology, for a story about high school students considering taking a gap year after graduation.
University of Cincinnati celebrates record number of graduates
April 27, 2026
UC will recognize a record number of graduates at its spring commencement in four ceremonies Thursday at Fifth Third Arena and Friday at Nippert Stadium.